10-K Decoder · All companies

Zevra Therapeutics, Inc.

ZVRA · FY2025 · Fiscal year ended Dec 31, 2025 · 10-K filed Mar 2026

Open the dashboardInfographicSummary

FY2025 key figures

$FY2025FY2024Change
Revenue$106M$23.6M+351%
Operating income−$62.9M−$87.0M+27.7%
Net income$77.6M−$106M

Questions

What was Zevra Therapeutics's revenue in FY2025?
$106M in FY2025 (Fiscal year ended Dec 31, 2025), +351% vs $23.6M a year earlier, per its 10-K filed Mar 2026.
Was Zevra Therapeutics profitable in FY2025?
Yes: net income was $77.6M and operating income −$62.9M in FY2025.